Document Detail


Synthetic byproducts of tocopherol oxidation as inhibitors of platelet function.
MedLine Citation:
PMID:  6815715     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Vitamin E and its fully oxidized form tocopherol quinone are known inhibitors of platelet aggregation. Previous results from our laboratory have shown that the quinone was approximately equal in effectiveness to vitamin E. A recent report of a far greater inhibitory activity of the quinone produced by nitric acid oxidation of vitamin E prompted this investigation. Our studies show that the unusually high inhibition of platelet aggregation, release and cyclooxygenase activity associated with nitric acid oxidized vitamin E is due to byproducts of the oxidation process and not due to tocopherol quinone. Treatment of vitamin E acetate, a substance of mild effect on aggregation and arachidonate metabolism of platelets, with nitric acid did not produce tocopherol quinone but exerted as potent an inhibition as oxidized vitamin E. We conclude that nitric acid oxidation is unsuitable for preparation of tocopherol quinone unless the latter is carefully isolated. Oxidation with permanganate proved to be an alternate method without these difficulties.
Authors:
R Mower; M Steiner
Related Documents :
3771735 - Effect of glucocorticoid on glycosaminoglycans synthesis in cultured mouse embryonic pa...
22866905 - Oxidative ipso-rearrangement performed by a hypervalent iodine reagent and its applicat...
1480155 - Modulation of phosphatidylethanolamine biosynthesis by exogenous ethanolamine and analo...
19138675 - Autophagy is upregulated in rats with status epilepticus and partly inhibited by vitami...
21647265 - Construction of cyclic enones via gold-catalyzed oxygen transfer reactions.
14682685 - Kinetics of the grignard reaction with silanes in diethyl ether and ether-toluene mixtu...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Prostaglandins     Volume:  24     ISSN:  0090-6980     ISO Abbreviation:  Prostaglandins     Publication Date:  1982 Aug 
Date Detail:
Created Date:  1983-01-07     Completed Date:  1983-01-07     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0320271     Medline TA:  Prostaglandins     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  137-47     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arachidonic Acid
Arachidonic Acids / blood
Blood Platelets / drug effects,  physiology*
Humans
Oxidation-Reduction
Platelet Aggregation / drug effects*
Structure-Activity Relationship
Tocopherols
Vitamin E / analogs & derivatives*,  pharmacology*
alpha-Tocopherol* / analogs & derivatives*
Grant Support
ID/Acronym/Agency:
HL 22951/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Arachidonic Acids; 1406-18-4/Vitamin E; 1406-66-2/Tocopherols; 506-32-1/Arachidonic Acid; 59-02-9/alpha-Tocopherol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relaxin inhibits prostacyclin release by the rat pregnant myometrium.
Next Document:  Effect of oestradiol 17 beta on prostaglandin biosynthesis by the uterus of ovariectomized rat and g...